ArticleCardiovascular diabetology2020

Cardiovascular risks and bleeding with non-vitamin K antagonist oral anticoagulant versus warfarin in patients with type 2 diabetes: a tapered matching cohort study.

Dahai Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.